Back to search

Article

Ex vivo human leukemia blood model illustrates limitations of cancer-targeting PEGylated nanoparticles

2024-05-31

Abstract excerpt

Antibody-directed targeting of chemotherapeutic nanomaterials to primary human cancers could improve efficacy and reduce off-target toxicities. We developed an ex vivo model to study the targeting of primary human Chronic Lymphocytic Leukemia (CLL) in whole blood samples from 15 subjects with CLL. Anti-CD20 targeted polyethylene glycol (PEG)-based nanoparticles had generally efficient targeting of CLL cells and lo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d0b08e35-0352-5ac6-9005-4741f6bb8cf9
DOI
10.1101/2024.05.29.24308091
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Ex vivo human leukemia blood model illustrates limitations of cancer-targeting PEGylated nanoparticlesDOI 10.1101/2024.05.29.24308091
Select a neighboring publication to make it the new centre.